
|Articles|July 12, 2004
Women have new patch for preventing osteoporosis
Clinicians will soon be able to offer postmenopausal women transdermal estrogen therapy that delivers half the dose of the lowest currently available dose of transdermal estrogen. The FDA recently approved estradiol transdermal system (Menostar, Berlex) 14 mcg/d for the prevention of postmenopausal osteoporosis. The product will be available later this summer.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Embedded Pharmacists Are Vital Yet Underutilized in Diabetes Care
2
The Prodigious PBM Pivot: How Supply Chain Entities Will Move Forward After CAA 2026
3
Executive Order Calls for Realignment of Childhood Vaccines
4
Pneumococcal Vaccination at 50 Years Old Can Improve Outcomes
5





























































